These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 2652521)
1. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial. Büsing M; Hölzer H; Schareck WD; Mellert J; Greger B; Hopt UT; Lauchart W Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521 [No Abstract] [Full Text] [Related]
2. Randomised trial of conversion from cyclosporin to azathioprine at one year after renal transplantation. Watson MA; Briggs JD; Junor BJ; McMillan MA; Macpherson SG; Murray G; Stewart RM Transplant Proc; 1989 Feb; 21(1 Pt 2):1583-4. PubMed ID: 2652514 [No Abstract] [Full Text] [Related]
3. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function. Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536 [No Abstract] [Full Text] [Related]
4. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation? Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519 [No Abstract] [Full Text] [Related]
5. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years. Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891 [No Abstract] [Full Text] [Related]
6. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation. Blümke M; Kirste G; Wanner U; Wilms H Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571 [No Abstract] [Full Text] [Related]
7. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine. Schulak JA; Moritz CE; Hricik DE Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560 [No Abstract] [Full Text] [Related]
8. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine. Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898 [No Abstract] [Full Text] [Related]
9. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth. Hodson EM; Knight JF; Sheil AG; Roy LP Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553 [No Abstract] [Full Text] [Related]
10. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function. Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497 [No Abstract] [Full Text] [Related]
11. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients. Cardella CJ; Harding ME; deVeber GA; Honey J; Cook GT Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065 [No Abstract] [Full Text] [Related]
12. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression. Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566 [No Abstract] [Full Text] [Related]
13. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy. Hourmant M; Buzelin F; Dubigeon P; Soulillou JP Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073 [No Abstract] [Full Text] [Related]
14. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation. Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515 [No Abstract] [Full Text] [Related]
15. Cadaver renal transplantation without maintenance steroids. Johnson RW; Mallick NP; Bakran A; Pearson RC; Scott PD; Dyer P; Donaghue D; Morris D; Gokal R Transplant Proc; 1989 Feb; 21(1 Pt 2):1581-2. PubMed ID: 2652513 [No Abstract] [Full Text] [Related]
16. A controlled trial of triple therapy in renal transplantation. Salaman JR; Griffin PJ; Ross WB; Williams JD Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061 [No Abstract] [Full Text] [Related]
17. Elective cyclosporine conversion from triple therapy. Chapman JR; Allen RD; Ekberg H; Lawrence S; Stewart JH Transplant Proc; 1989 Feb; 21(1 Pt 2):1631-2. PubMed ID: 2652532 [No Abstract] [Full Text] [Related]
18. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone. MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557 [No Abstract] [Full Text] [Related]
19. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy. Leaker B; Neild GH; Rudge C; Mansell M; Thompson FD Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501 [No Abstract] [Full Text] [Related]
20. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality. Light JA; Aquino A; Ali A; Rodriguez R; Ali S Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897 [No Abstract] [Full Text] [Related] [Next] [New Search]